Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.76% | 167.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.76% | 167.15% | |||
| Cost of Revenue | -2.77% | 244.51% | |||
| Gross Profit | -2.76% | 127.96% | |||
| SG&A Expenses | -2.74% | -22.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | -29.71% | |||
| Operating Income | 2.73% | 58.05% | |||
| Income Before Tax | 2.74% | 55.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.74% | 55.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.74% | 55.74% | |||
| EBIT | 2.73% | 58.05% | |||
| EBITDA | 2.75% | 59.96% | |||
| EPS Basic | 0.00% | 50.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 50.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||